ACCREDITATION STATEMENT
31st Clinical Applications for Age Management Medicine Conference
“In support of improving patient care, this activity has been planned and implemented with Foundation for Care Management and Age Management Medicine Group.
Foundation for Care Management is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.”
AMA PRA Category 1 Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Foundation for Care Management (FCM) and Age Management Medicine Group. The Foundation for Care Management is accredited by the ACCME to provide continuing medical education for physicians.
FMC designates this educational activity for a maximum of 26 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in this activity.
The ACCME defines an ineligible company(s) as those whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.
Nursing Statement
Foundation for Care Management is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Foundation for Care Management has designated this activity as approved for 26 hours of nursing continuing professional development.
Pharmacy Statement
The foundation for Care Management is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Program #0347-9999-21-012-L01-P Objectives appropriate for pharmacists. This activity is 26 Contact Hours Pharmacy Credit. *This CME is Knowledge Based (K). Initial release November 4, 2021.
Program Reviewers
Mary Corry, MSN and Dana Burnett, M. Ed have no relevant financial relationships to disclose.
All relevant financial relationships for faculty, planning committee and program reviewers have been reviewed and mitigated.
Conflict of Interest Disclosure Policy
Identify, Mitigate, and Disclose Relevant Financial Relationships
Many healthcare professionals have financial relationships with ineligible companies. These relationships must not be allowed to influence accredited continuing education.
The Foundation for Care Management (FCM) as the accredited provider is responsible for identifying relevant financial relationships between individuals in control of educational content and ineligible companies and managing these to ensure they do not introduce commercial bias into the education. Financial relationships are defined as relevant if the educational content is related to the business lines or products of the ineligible company. As an accredited provider FCM collects information from planners, faculty and other in control of educational content and conducts an extensive review process. Financial relationships are identified, reviewed and mitigated. In some cases, speakers and committee members may be excluded. All relevant financial relationships are disclosed to learners in this handout as required by the ACCME.
FACULTY/Planner — DISCLOSURES
The Foundation for Care Management (FCM) requires everyone in a position to control the content of this activity to disclose any relevant financial conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by The Foundation for Care Management (FCM) for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
Conference Planning Committee – Disclosure
Florence Comite, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Mary L. Corry, R.N. – No Relevant Relationships with a Commercial Interest to Disclose
Mark L. Gordon, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Rob A. Kominiarek, D.O. – No Relevant Relationships with a Commercial Interest to Disclose
Cesar M. Pellerano, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
John Rush, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
George Shapiro, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Faculty
Christopher Arboleda, MS – No Relevant Relationships with a Commercial Interest to Disclose
Michale Barber, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
John C. Carrozzella, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
William Clearfield, D.O. – No Relevant Relationships with a Commercial Interest to Disclose
Florence Comite, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Dana Delgardo, FNP – No Relevant Relationships with a Commercial Interest to Disclose
Carolyn DeLucia, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Angela DeRosa, D.O. – Belmar Pharma, Medical Director; Hormone Health Institute, Owner/ Founder
Derrick DeSilva, Jr., M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Elliott Dinetz, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Benjamin Gonzalez, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Mark Gordon, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Jonathan Keith, M.D., FACS – No Relevant Relationships with a Commercial Interest to Disclose
Dobri Kiprov, M.D. – Fresenius Medical Care, Stock or Stock Options
Edwin N. Lee, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Jeffry Life, M.D., Ph.D. – No Relevant Relationships with a Commercial Interest to Disclose
Ashley Madison – No Relevant Relationships with a Commercial Interest to Disclose
Luis Martinez, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Kathy Maupin, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Abraham Morgenthaler, M.D. – Antares, Consultant; Acerus, Consultant; Bayer, Advisory Committee Member; Marius, Consultant; Endo, Research Gran
Beatriz Olsen, M.D., FACP – No Relevant Relationships with a Commercial Interest to Disclose
Cesar M. Pellerano, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Theresa Ramsey, NMD – No Relevant Relationships with a Commercial Interest to Disclose
Neal Rouzier, M.D. – Evexias, Speaker Bureau
Jodie Scholes – Green Sunshine, Ownership
Jin-Xiong She, Ph.D. – Jinfiniti Precision Medicine, Executive Role/Ownership
Jason Sonners, D.C., DCBCN – No Relevant Relationships with a Commercial Interest to Disclose
Paul Thompson, M.D. – Launch Medical, Executive Role, Organicel, Stock Options
Dushyant Viswanathan, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Dr. Payam Zand – No Relevant Relationships with a Commercial Interest to Disclose